SCHEMBL2514937

SCHEMBL2514937

COc1cc(N(C(=N)S)C(=O)C(CCCCCl)c2ccc(F)cc2)ccc1-c1nc(C)no1

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 3/20 0.33
HCRTR2 O43614 3/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33
APH1A Q96BI3 1/20 0.33
PSENEN Q9NZ42 1/20 0.33
KMT2A Q03164 1/20 0.32
CHEK1 O14757 1/20 0.32
F11 P03951 4/20 0.32
KLKB1 P03952 4/20 0.32
CRHR1 P34998 4/20 0.31
MAPT P10636 3/20 0.31
GAA P10253 2/20 0.31
TP53 P04637 2/20 0.31
OPRK1 P41145 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2487524 0.82 PSEN1 (0.35) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL2514488 0.80 PSEN1 (0.39) HCRTR1HCRTR2PSEN1PSEN2APH1B
SCHEMBL2514939 0.78 PSEN1 (0.39) HCRTR1HCRTR2PSEN1PSEN2APH1B
SCHEMBL961340 0.74 PSEN1 (0.38) HCRTR1HCRTR2PSEN1PSEN2APH1B
SCHEMBL960321 0.67 PSEN1 (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL963212 0.63 F11 (0.36) KMT2AF11KLKB1MAPT
SCHEMBL18031476 0.61 KMT2A (0.54) KMT2ACHEK1F11KLKB1MAPT
SCHEMBL18031477 0.60 MAPT (0.53) KMT2ACHEK1MAPTGAATP53
SCHEMBL962540 0.59 POLB (0.41)
SCHEMBL4854918 0.58 CHEK1 (0.48) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379553-A1 BICYCLIC COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION Bristol-Myers Squibb Company (US) 2011-10-26 EP disclosed
WO-2010083141-A1 BICYCLIC COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-22 WO disclosed